Total Payments
$1,277
2024 Payments
$383.21
Companies
18
Transactions
62
Medicare Patients
589
Medicare Billing
$57,313
Payment Breakdown by Category
Food & Beverage$1,277 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,277 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $244.69 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $158.00 | 8 | $0 (2024) |
| Mylan Specialty L.P. | $148.42 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $104.53 | 6 | $0 (2024) |
| Grifols USA, LLC | $89.90 | 4 | $0 (2024) |
| Ethicon Inc. | $88.37 | 1 | $0 (2024) |
| United Therapeutics Corporation | $80.00 | 4 | $0 (2024) |
| GENZYME CORPORATION | $79.94 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $60.26 | 4 | $0 (2024) |
| Shionogi Inc | $37.50 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $383.21 | 16 | Ethicon Inc. ($88.37) |
| 2023 | $628.57 | 32 | AstraZeneca Pharmaceuticals LP ($186.74) |
| 2022 | $264.96 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($60.35) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $88.37 | General |
| Category: Endo-Mechanical | ||||||
| 06/15/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/23/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/17/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/03/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Airway Clearance Device | ||||||
| 04/02/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Pulmonology | ||||||
| 03/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/18/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 02/28/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 01/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.16 | General |
| 01/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: RESPIRATORY | ||||||
| 01/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Respiratory | ||||||
| 12/15/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/12/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Respiratory | ||||||
| 11/10/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $12.99 | General |
| 11/08/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Pulmonology | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/09/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 451 | 516 | $130,288 | $38,047 |
| 2022 | 8 | 120 | 146 | $58,655 | $16,471 |
| 2021 | 1 | 18 | 19 | $12,825 | $2,795 |
Total Patients
589
Total Services
681
Medicare Billing
$57,313
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 47 | $31,725 | $7,455 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 62 | $16,120 | $5,866 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $14,615 | $4,463 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 34 | $11,900 | $4,353 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 50 | $8,750 | $3,206 | 36.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,940 | $1,868 | 31.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 43 | 45 | $6,975 | $1,866 | 26.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 41 | 42 | $6,930 | $1,673 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 28 | $5,040 | $1,644 | 32.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,680 | $1,355 | 29.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 44 | 44 | $7,700 | $1,222 | 15.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,685 | $1,086 | 29.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,890 | $721.31 | 38.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 35 | $2,275 | $584.46 | 25.7% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 12 | 14 | $1,512 | $538.58 | 35.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 19 | $551.00 | $144.59 | 26.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 45 | $30,375 | $7,530 | 24.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 21 | $7,350 | $2,899 | 39.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $7,425 | $2,276 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,345 | $1,405 | 32.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 18 | $3,240 | $977.04 | 30.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 13 | 13 | $2,015 | $570.31 | 28.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 12 | 12 | $1,980 | $491.40 | 24.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 11 | 11 | $1,925 | $322.52 | 16.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 18 | 19 | $12,825 | $2,795 | 21.8% |
About Nathaniel Meier
Nathaniel Meier is a Critical Care Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1508228255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nathaniel Meier has received a total of $1,277 in payments from pharmaceutical and medical device companies, with $383.21 received in 2024. These payments were reported across 62 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,277).
As a Medicare-enrolled provider, Meier has provided services to 589 Medicare beneficiaries, totaling 681 services with total Medicare billing of $57,313. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Greensboro, NC
- Active Since 03/22/2016
- Last Updated 07/30/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1508228255
Products in Payments
- YUPELRI (Drug) $136.41
- TAGRISSO (Drug) $124.98
- OFEV (Drug) $95.36
- Prolastin-C Liquid (Biological) $89.90
- Monarch Platform (Device) $88.37
- TYVASO (Drug) $80.00
- DUPIXENT (Biological) $79.94
- NUCALA (Biological) $61.57
- TEZSPIRE (Biological) $49.94
- DIFICID (Drug) $47.27
- BREZTRI (Drug) $44.51
- TRELEGY ELLIPTA (Drug) $42.96
- Fetroja (Drug) $37.50
- Arikayce (Drug) $37.14
- TEFLARO (Drug) $31.13
- ACTHAR (Biological) $28.14
- Hillrom - Vest System Model 105 Home Care (Device) $26.45
- FASENRA (Biological) $25.26
- Da Vinci Surgical System (Device) $16.99
- PURIFIED CORTROPHIN GEL (Drug) $16.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greensboro
Dr. Patrick Wright, M.d, M.D
Critical Care Medicine — Payments: $4,211
Critical Care Medicine $4,211
Dr. Kenneth Burns, M.d, M.D
Critical Care Medicine — Payments: $2,844
Critical Care Medicine $2,844
Chi Jane Ellison, M.d, M.D
Critical Care Medicine — Payments: $2,835
Critical Care Medicine $2,835
Dr. David Simonds, M.d, M.D
Critical Care Medicine — Payments: $2,561
Critical Care Medicine $2,561
Dr. Omar Albustami, Md, MD
Critical Care Medicine — Payments: $1,867
Critical Care Medicine $1,867
Taylar Baity, Dnp, DNP
Critical Care Medicine — Payments: $826.69
Critical Care Medicine $826.69